Analysts expect Marchex, Inc. (NASDAQ:MCHX) to report earnings of ($0.04) per share for the current quarter, according to Zacks. Two analysts have issued estimates for Marchex’s earnings, with estimates ranging from ($0.05) to ($0.02). Marchex posted earnings per share of ($0.06) in the same quarter last year, which suggests a positive year over year growth rate of 33.3%. The business is scheduled to issue its next earnings results on Tuesday, March 1st.
According to Zacks, analysts expect that Marchex will report full year earnings of ($0.13) per share for the current year, with EPS estimates ranging from ($0.14) to ($0.12). For the next year, analysts expect that the business will post earnings of ($0.07) per share, with EPS estimates ranging from ($0.09) to ($0.04). Zacks Investment Research’s EPS averages are a mean average based on a survey of research firms that that provide coverage for Marchex.
Marchex (NASDAQ:MCHX) last released its quarterly earnings data on Tuesday, November 9th. The technology company reported ($0.01) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.05) by $0.04. Marchex had a negative return on equity of 19.29% and a negative net margin of 14.53%. The company had revenue of $13.70 million for the quarter, compared to the consensus estimate of $14.37 million. During the same quarter last year, the business posted ($0.05) EPS.
Several research firms recently weighed in on MCHX. TheStreet raised Marchex from a “d” rating to a “c-” rating in a report on Friday, December 3rd. Zacks Investment Research downgraded Marchex from a “buy” rating to a “hold” rating in a report on Thursday, October 7th.
In related news, major shareholder Edenbrook Capital, Llc bought 798,714 shares of the business’s stock in a transaction on Monday, November 22nd. The shares were purchased at an average cost of $2.50 per share, with a total value of $1,996,785.00. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. 18.55% of the stock is currently owned by insiders.
Several hedge funds have recently bought and sold shares of MCHX. Ergoteles LLC bought a new position in shares of Marchex in the 2nd quarter worth about $51,000. B. Riley Financial Inc. raised its position in shares of Marchex by 41.7% in the 2nd quarter. B. Riley Financial Inc. now owns 2,199,098 shares of the technology company’s stock worth $6,729,000 after acquiring an additional 647,548 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Marchex by 3.9% in the 2nd quarter. Geode Capital Management LLC now owns 262,753 shares of the technology company’s stock worth $804,000 after acquiring an additional 9,935 shares in the last quarter. Edenbrook Capital LLC raised its position in shares of Marchex by 0.7% in the 2nd quarter. Edenbrook Capital LLC now owns 13,445,095 shares of the technology company’s stock worth $41,142,000 after acquiring an additional 100,000 shares in the last quarter. Finally, State Street Corp increased its position in Marchex by 706.3% in the 2nd quarter. State Street Corp now owns 129,115 shares of the technology company’s stock valued at $395,000 after buying an additional 113,101 shares in the last quarter. 57.98% of the stock is owned by hedge funds and other institutional investors.
Shares of NASDAQ MCHX traded up $0.02 during mid-day trading on Wednesday, hitting $2.66. 1,337 shares of the stock traded hands, compared to its average volume of 90,379. Marchex has a twelve month low of $1.62 and a twelve month high of $3.67. The company has a market cap of $110.53 million, a PE ratio of -14.78 and a beta of 1.86. The firm has a 50 day simple moving average of $2.91 and a two-hundred day simple moving average of $2.92.
Marchex Company Profile
Marchex, Inc operates as a conversational analytics and solutions company which helps businesses connect, drive, measure, convert callers into customers, and connects the voice of the customer to business. It offers Marchex call analytics platform, Marchex call marketplace and Marchex local leads products to automotive, travel and hospitality, telecommunications, insurance, home services, digital agencies, healthcare, education & careers, financial services, legal, real estate and senior living industries.
See Also: Initial Coin Offering (ICO)
Get a free copy of the Zacks research report on Marchex (MCHX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Should you invest $1,000 in Marchex right now?
Before you consider Marchex, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Marchex wasn’t on the list.
While Marchex currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
